Beijing ESWIN Computing Technology’s proposed Hong Kong flotation is approaching a critical scheduled date without yet becoming a completed transaction. According to the South China Morning Post, the China-based RISC-V chip company was aiming to raise about US$300 million and planned to begin soliciting orders from institutional and public investors on Monday, September 28. The newspaper, citing people familiar with the matter, said trading was expected to begin on October 8. Each element remains a reported plan, leaving the size, timetable, allocation, and eventual trading outcome unresolved as of September 27.
The company’s formal issuer name matters in assessing that plan. The HKEX Application Proof identifies the applicant as Beijing ESWIN Computing Technology Co., Ltd., also known as Eswin Computing. It separately identifies Beijing ESWIN Technology Group Co., Ltd. as ESWIN Group and one of the company’s single largest shareholders. Keeping those entities distinct is essential when following the application, financial disclosures, and prospective deal. The official document is an Application Proof in draft form, whose warning says its content is incomplete, can change materially, and gives no assurance that the company will proceed with an offering.
Eswin’s US$300 Million IPO Target and October Schedule
The reported fundraising target places Eswin in a Hong Kong market where semiconductor issuers are pursuing capital for long development cycles and manufacturing relationships. SCMP’s September 25 report described the intended raise as around US$300 million. The Standard, citing International Financing Review on September 23, reported the target as US$300 million, or HK$2.34 billion. Those figures describe an ambition reported before an offering, rather than proceeds received by Eswin.
SCMP also reported that Eswin had passed its listing hearing with Hong Kong Exchanges and Clearing. KrASIA reported on September 23 that the company had passed the HKEX hearing and released a post-hearing information pack on September 21. The milestones show progress through the application process. They do not establish an offer price, number of shares, ticker, valuation, allotment, or completed listing.
That distinction is especially important in the days before the reported September 28 order-solicitation start. The Application Proof says that publication of the draft document does not oblige the company or its advisers to proceed, and that its contents may differ from an eventual final listing document. Investors and industry observers therefore have a defined set of near-term markers to watch: whether the solicitation begins as reported, whether a final document appears, and whether HKEX later confirms a listing and trading event. Until then, the October 8 date remains an expectation reported by SCMP.
RISC-V Chips, Fabless Design, and Eswin’s Revenue Record
Eswin’s filing describes it as a China-based provider of chip products oriented around RISC-V. KrASIA characterizes the company as fabless, meaning it designs chips and outsources manufacturing. Its stated product areas include human-machine interaction, multimedia processing, interconnect, and computing chips. That mix provides the operating context for a possible public offering centered on a company whose business spans device-facing functions and computing products, rather than a single chip category.
The financial record reported around the application shows revenue growth alongside continuing losses. SCMP reported that 2025 revenue reached 2.4 billion yuan, up 20% year over year, while the company recorded a 1.5 billion yuan net loss. KrASIA, citing figures in Eswin’s HKEX filing, put 2025 revenue more precisely at RMB2,431.2 million. The difference reflects a rounded figure in the SCMP report and a more detailed filing-based presentation, with both accounts pointing to higher revenue during a loss-making year.
First-quarter 2026 figures add a more recent measure of that trajectory. The Standard reported revenue of RMB494.2 million for the first three months, an 18.4% increase year over year, and said net loss narrowed 6% to RMB374.9 million. KrASIA likewise reported RMB494.2 million in first-quarter revenue, compared with RMB417.5 million a year earlier. These figures do not establish a path to profitability. They show that Eswin entered the reported IPO window with rising revenue and a quarterly loss still measured in hundreds of millions of yuan.
The Application Proof also describes the company’s future business as dependent on its ability to improve margins and develop higher-margin products, while continuing significant research and development investment. It identifies risks from customer concentration, competition from architectures including x86 and Arm, demand conditions, inventory management, and past net losses and operating cash outflows. For a RISC-V-focused designer, those disclosures place technical development and commercial adoption at the center of the listing narrative.
Hong Kong Chip Listings Frame the RISC-V Capital Question
A conditional Eswin transaction would give Hong Kong investors another RISC-V-focused chip applicant to assess. EastFrontier has separately followed Baidu’s Chip Unit Kunlunxin Targets a Hong Kong IPO. Eswin’s own case should be assessed on the facts in its application: a RISC-V-oriented fabless company reporting rising revenue, persistent losses, and a fundraising target that has yet to be completed.
EastFrontier has also covered Nexchip’s Hong Kong IPO filing. Those separate proposals provide broader context, but comparisons with them are outside the source-bounded evidence reviewed for Eswin. The immediate question here is whether Eswin’s own reported timetable progresses from hearing clearance to a confirmed offering and listing.
For Eswin, the immediate focus should stay narrow and evidence-based. Its named issuer, RISC-V-oriented product scope, hearing milestone, and reported revenue figures are supported by the application materials and contemporary reporting. The US$300 million target, September 28 solicitation timetable, and October 8 debut date remain subject to the qualifications attached to their reporting and the draft HKEX document. A final prospectus, allotment announcement, and confirmed listing notice would be needed before those plans could be treated as completed events.